Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Semi Equipment Analysis -- Ignore unavailable to you. Want to Upgrade?

To: StanX Long who wrote (13322)	2/12/2004 10:27:07 PM
From: StanX Long	Read Replies (1) \| Respond to of 95757

Zyomyx Raises $10M Online staff -- Electronic News, 2/12/2004 Biochip maker Zyomyx, a late stage company, has won $10 million in venture funding in a round led by CSFB Private Equity and including many existing investors. The Hayward, Calif.-based company develops silicon-based biochips for protein analysis. "We are extremely gratified by the strong interest from investors in this late stage round of financing," said Bob Monaghan, president and CEO, in a statement. "This investment provides for line expansion of our novel biochip platform, which we introduced with the Human Cytokine Biochip in 2003." The company's customers include top pharmaceutical, biotech and academic institutions, Zyomyx said. The company expects to launch its new Murine Cytokine Biochip in April, and some additional biochips later this year. Also participating in the round of funding were existing investors Alloy Ventures, Lilly BioVentures, Hambrecht & Quist Capital Management, Mediphase Venture Partners and BioOne Capital Pte Ltd., the dedicated biomedical services investment arm of the Singapore Economic Development Board.